BTBD9 Protein (Transcript Variant 3) (Myc-DYKDDDDK Tag)
-
- Target Alle BTBD9 Proteine anzeigen
- BTBD9 (BTB (POZ) Domain Containing 9 (BTBD9))
- Protein-Typ
- Recombinant
- Proteineigenschaft
- Transcript Variant 3
-
Spezies
- Human
-
Quelle
- HEK-293 Cells
- Aufreinigungstag / Konjugat
- Dieses BTBD9 Protein ist gelabelt mit Myc-DYKDDDDK Tag.
- Applikation
- Antibody Production (AbP), Standard (STD)
- Produktmerkmale
-
- Recombinant human BTBD9 (transcript variant 3) protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
- Reinheit
- > 80 % as determined by SDS-PAGE and Coomassie blue staining
- Top Product
- Discover our top product BTBD9 Protein
-
-
- Applikationshinweise
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays - Kommentare
-
The tag is located at the C-terminal.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 50 μg/mL
- Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
- Lagerung
- -80 °C
- Informationen zur Lagerung
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- Target
- BTBD9 (BTB (POZ) Domain Containing 9 (BTBD9))
- Andere Bezeichnung
- Btbd9 (BTBD9 Produkte)
- Hintergrund
- This locus encodes a BTB/POZ domain-containing protein. This domain is known to be involved in protein-protein interactions. Polymorphisms at this locus have been reported to be associated with susceptibility to Restless Legs Syndrome and may also be associated with Tourette Syndrome. Alternatively spliced transcript variants have been described.
- Molekulargewicht
- 61.4 kDa
- NCBI Accession
- NP_689946
- Pathways
- Transition Metal Ion Homeostasis
-